1. Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol. 2019;54:407-19.

https://doi.org/10.3892/ijo.2018.4661

PMid:30570109 PMCid:PMC6317661

2. Pulito C, Cristaudo A, Porta CL, Zapperi S, Blandino G, Morrone A, et al. Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 2020;39:210.

https://doi.org/10.1186/s13046-020-01715-7

PMid:33028357 PMCid:PMC7542970

3. Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin. 2022;72:57-77.

https://doi.org/10.3322/caac.21704

PMid:34714553 

4. Ueno T, Yatsuoka W, Ishiki H, Miyano K, Uezono Y. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study. BMC Cancer. 2022;22:90.

https://doi.org/10.1186/s12885-021-09107-6

PMid:35062896 PMCid:PMC8780715

5. Guler Avci G, Erdim I, Ozmen ZC, Gevrek F, Colak S, Demirsoy MS, et al. The effect of systemic application of propolis on tongue damage and oral mucositis in rats exposed to radiation. Eur Arch Otorhinolaryngol. 2022;279:1043-52.

https://doi.org/10.1007/s00405-021-07159-9

PMid:34746967 

6. Gruber S, Bozsaky E, Roitinger E, Schwarz K, Schmidt M, Dörr W. Early inflammatory changes in radiation-induced oral mucositis : Effect of pentoxifylline in a mouse model. Strahlenther Onkol. 2017;193:499-507.

https://doi.org/10.1007/s00066-017-1119-8

PMid:28258409 PMCid:PMC5438416

7. Cummings JH. Short chain fatty acids in the human colon. Gut. 1981;22:763-79.

https://doi.org/10.1136/gut.22.9.763

PMid:7028579 PMCid:PMC1419865

8. Zhou B, Te B, Wang L, Gao Y, He Q, Yan Z, et al. Combination of sodium butyrate and probiotics ameliorates severe burn-induced intestinal injury by inhibiting oxidative stress and inflammatory response. Burns. 2022;48:1213-20.

https://doi.org/10.1016/j.burns.2021.11.009

PMid:34903409 

9. Sawicki CM, Livingston KA, Obin M, Roberts SB, Chung M, McKeown NM. Dietary Fiber and the Human Gut Microbiota: Application of Evidence Mapping Methodology. Nutrients. 2017;9.

https://doi.org/10.3390/nu9020125

PMid:28208609 PMCid:PMC5331556

10. Lee C, Kim BG, Kim JH, Chun J, Im JP, Kim JS. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. Int Immunopharmacol. 2017;51:47-56.

https://doi.org/10.1016/j.intimp.2017.07.023

PMid:28802151 

11. Ramos MG, Bambirra EA, Cara DC, Vieira EC, Alvarez-Leite JI. Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets. Nutr Cancer. 1997;28:212-7.

https://doi.org/10.1080/01635589709514577

PMid:9290130 

12. Ferreira TM, Leonel AJ, Melo MA, Santos RRG, Cara DC, Cardoso VN, et al. Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-Fluorouracil administration. Lipids. 2012;47:669-78.

https://doi.org/10.1007/s11745-012-3680-3

PMid:22648862 

13. Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology. 2016;5:e73.

https://doi.org/10.1038/cti.2016.17

PMid:27195116 PMCid:PMC4855267

14. Jung TH, Park JH, Jeon WM, Han KS. Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway. Nutr Res Pract. 2015;9:343-9.

https://doi.org/10.4162/nrp.2015.9.4.343

PMid:26244071 PMCid:PMC4523476

15. Ohata A, Usami M, Miyoshi M. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation. Nutrition. 2005;21:838-47.

https://doi.org/10.1016/j.nut.2004.12.004

PMid:15975492 

16. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008;52.

https://doi.org/10.1016/j.cden.2007.10.002

PMid:18154865 PMCid:PMC2266835

17. Bian L, Han G, Zhao CW, Garl PJ, Wang XJ. The role of Smad7 in oral mucositis. Protein Cell. 2015;6:160-9.

https://doi.org/10.1007/s13238-014-0130-4

PMid:25566830 PMCid:PMC4348243

18. Shimamura Y, Takeuchi I, Terada H, Makino K. Therapeutic Effect of GGsTop, Selective Gamma-glutamyl Transpeptidase Inhibitor, on a Mouse Model of 5-Fluorouracil-induced Oral Mucositis. Anticancer Res. 2019;39:201-6.

https://doi.org/10.21873/anticanres.13098

PMid:30591459 

19. Shimamura Y, Takeuchi I, Terada H, Makino K. A Mouse Model for Oral Mucositis Induced by Cancer Chemotherapy. Anticancer Res. 2018;38:307-12.

https://doi.org/10.21873/anticanres.12223

PMid:29277788

20. Wilson PM, Danenberg PV, Johnston PG, Lenz HJ, Ladner RD. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy. Nat Rev Clin Oncol. 2014;11:282-98.

https://doi.org/10.1038/nrclinonc.2014.51

PMid:24732946 

21. Zaura E, Brandt BW, Teixeira de Mattos MJ, Buijs MJ, Caspers MPM, Rashid MU, et al. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces. mBio. 2015;6:e01693-e15.

https://doi.org/10.1128/mBio.01693-15

PMid:26556275 PMCid:PMC4659469

22. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int. 2012;95:50-60.

https://doi.org/10.5740/jaoacint.SGE_Macfarlane

PMid:22468341 

23. Jacobi SK, Odle J. Nutritional factors influencing intestinal health of the neonate. Adv Nutr. 2012;3:687-96.

https://doi.org/10.3945/an.112.002683

PMid:22983847 PMCid:PMC3648750

24. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104-19.

https://doi.org/10.1111/j.1365-2036.2007.03562.x

PMid:17973645 

25. Li G, Lin J, Zhang C, Gao H, Lu H, Gao X, et al. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes. 2021;13:1968257.

https://doi.org/10.1080/19490976.2021.1968257

PMid:34494943 PMCid:PMC8437544

26. Chen G, Ran X, Li B, Li Y, He D, Huang B, et al. Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model. EBioMedicine. 2018;30:317-25.

https://doi.org/10.1016/j.ebiom.2018.03.030

PMid:29627390 PMCid:PMC5952406

27. Sonis ST. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med. 2002;13:380-9.

https://doi.org/10.1177/154411130201300502

PMid:12393757 

28. Fan WJ, Li HP, Zhu HS, Sui SP, Chen PG, Deng Y, et al. NF-κB is involved in the LPS-mediated proliferation and apoptosis of MAC-T epithelial cells as part of the subacute ruminal acidosis response in cows. Biotechnol Lett. 2016;38:1839-49.

https://doi.org/10.1007/s10529-016-2178-0

PMid:27447467 

29. Sun SC. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17:545-58.

https://doi.org/10.1038/nri.2017.52

PMid:28580957 PMCid:PMC5753586

30. Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.

https://doi.org/10.1186/1476-4598-12-86

PMid:23915189 PMCid:PMC3750319